151 related articles for article (PubMed ID: 35426792)
21. Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Hughes E; Tshiaba P; Wagner S; Judkins T; Rosenthal E; Roa B; Gallagher S; Meek S; Dalton K; Hedegard W; Adami CA; Grear DF; Domchek SM; Garber J; Lancaster JM; Weitzel JN; Kurian AW; Lanchbury JS; Gutin A; Robson ME
JCO Precis Oncol; 2021; 5():. PubMed ID: 34036224
[TBL] [Abstract][Full Text] [Related]
22. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
[TBL] [Abstract][Full Text] [Related]
23. A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
Allman R; Spaeth E; Lai J; Gross SJ; Hopper JL
PLoS One; 2021; 16(1):e0245375. PubMed ID: 33481864
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic.
Saghatchian M; Abehsera M; Yamgnane A; Geyl C; Gauthier E; Hélin V; Bazire M; Villoing-Gaudé L; Reyes C; Gentien D; Golmard L; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2022 Apr; 192(2):375-383. PubMed ID: 34994879
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.
Li J; Holm J; Bergh J; Eriksson M; Darabi H; Lindström LS; Törnberg S; Hall P; Czene K
Ann Oncol; 2015 Mar; 26(3):517-22. PubMed ID: 25488685
[TBL] [Abstract][Full Text] [Related]
26. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Mavaddat N; Michailidou K; Dennis J; Lush M; Fachal L; Lee A; Tyrer JP; Chen TH; Wang Q; Bolla MK; Yang X; Adank MA; Ahearn T; Aittomäki K; Allen J; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Auer PL; Auvinen P; Barrdahl M; Beane Freeman LE; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Brenner H; Brentnall A; Brock IW; Brooks-Wilson A; Brucker SY; Brüning T; Burwinkel B; Campa D; Carter BD; Castelao JE; Chanock SJ; Chlebowski R; Christiansen H; Clarke CL; Collée JM; Cordina-Duverger E; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dumont M; Durcan L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fletcher O; Flyger H; Försti A; Fritschi L; Gabrielson M; Gago-Dominguez M; Gapstur SM; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Gilyazova IR; Glendon G; Goldberg MS; Goldgar DE; González-Neira A; Grenaker Alnæs GI; Grip M; Gronwald J; Grundy A; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hankinson SE; Harkness EF; Hart SN; He W; Hein A; Heyworth J; Hillemanns P; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Jakimovska M; Jakubowska A; Janni W; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kaczmarek K; Kataja V; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Knight JA; Ko YD; Kosma VM; Koutros S; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Lilyquist J; Lindblom A; Lindström S; Lissowska J; Lo WY; Loibl S; Long J; Lubiński J; Lux MP; MacInnis RJ; Maishman T; Makalic E; Maleva Kostovska I; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Martinez ME; Mavroudis D; McLean C; Meindl A; Menon U; Middha P; Miller N; Moreno F; Mulligan AM; Mulot C; Muñoz-Garzon VM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Nielsen SF; Nordestgaard BG; Norman A; Offit K; Olson JE; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Peto J; Pinchev M; Plaseska-Karanfilska D; Polley EC; Prentice R; Presneau N; Prokofyeva D; Purrington K; Pylkäs K; Rack B; Radice P; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Robson M; Romero A; Ruddy KJ; Ruebner M; Saloustros E; Sandler DP; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schürmann P; Schwentner L; Scott C; Scott RJ; Seynaeve C; Shah M; Sherman ME; Shrubsole MJ; Shu XO; Slager S; Smeets A; Sohn C; Soucy P; Southey MC; Spinelli JJ; Stegmaier C; Stone J; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Truong T; Tzardi M; Ulmer HU; Untch M; Vachon CM; van Veen EM; Vijai J; Weinberg CR; Wendt C; Whittemore AS; Wildiers H; Willett W; Winqvist R; Wolk A; Yang XR; Yannoukakos D; Zhang Y; Zheng W; Ziogas A; ; ; ; Dunning AM; Thompson DJ; Chenevix-Trench G; Chang-Claude J; Schmidt MK; Hall P; Milne RL; Pharoah PDP; Antoniou AC; Chatterjee N; Kraft P; García-Closas M; Simard J; Easton DF
Am J Hum Genet; 2019 Jan; 104(1):21-34. PubMed ID: 30554720
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women.
Hou C; Xu B; Hao Y; Yang D; Song H; Li J
BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775
[TBL] [Abstract][Full Text] [Related]
29. Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
Collister JA; Liu X; Littlejohns TJ; Cuzick J; Clifton L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):812-820. PubMed ID: 38630597
[TBL] [Abstract][Full Text] [Related]
30. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
[TBL] [Abstract][Full Text] [Related]
31. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
[TBL] [Abstract][Full Text] [Related]
32. Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.
Yang X; Eriksson M; Czene K; Lee A; Leslie G; Lush M; Wang J; Dennis J; Dorling L; Carvalho S; Mavaddat N; Simard J; Schmidt MK; Easton DF; Hall P; Antoniou AC
J Med Genet; 2022 Dec; 59(12):1196-1205. PubMed ID: 36162852
[TBL] [Abstract][Full Text] [Related]
33. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
[TBL] [Abstract][Full Text] [Related]
34. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
35. Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
Cuzick J; Brentnall AR; Segal C; Byers H; Reuter C; Detre S; Lopez-Knowles E; Sestak I; Howell A; Powles TJ; Newman WG; Dowsett M
J Clin Oncol; 2017 Mar; 35(7):743-750. PubMed ID: 28029312
[TBL] [Abstract][Full Text] [Related]
36. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
Borde J; Laitman Y; Blümcke B; Niederacher D; Weber-Lassalle K; Sutter C; Rump A; Arnold N; Wang-Gohrke S; Horváth J; Gehrig A; Schmidt G; Dutrannoy V; Ramser J; Hentschel J; Meindl A; Schroeder C; Wappenschmidt B; Engel C; Kuchenbaecker K; Schmutzler RK; Friedman E; Hahnen E; Ernst C
BMC Cancer; 2022 Jun; 22(1):706. PubMed ID: 35761208
[TBL] [Abstract][Full Text] [Related]
37. Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 Model.
Porterhouse MD; Paul S; Lieberenz JL; Stempel LR; Levy MA; Alvarado R
Ann Surg Oncol; 2022 Oct; 29(10):6419-6425. PubMed ID: 35790586
[TBL] [Abstract][Full Text] [Related]
38. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
Brentnall AR; Cohn WF; Knaus WA; Yaffe MJ; Cuzick J; Harvey JA
J Breast Imaging; 2019 Jun; 1(2):99-106. PubMed ID: 31423486
[TBL] [Abstract][Full Text] [Related]
39. The contributions of breast density and common genetic variation to breast cancer risk.
Vachon CM; Pankratz VS; Scott CG; Haeberle L; Ziv E; Jensen MR; Brandt KR; Whaley DH; Olson JE; Heusinger K; Hack CC; Jud SM; Beckmann MW; Schulz-Wendtland R; Tice JA; Norman AD; Cunningham JM; Purrington KS; Easton DF; Sellers TA; Kerlikowske K; Fasching PA; Couch FJ
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25745020
[TBL] [Abstract][Full Text] [Related]
40. An alternative approach to selecting patients for high-risk screening with breast MRI.
Hollingsworth AB; Stough RG
Breast J; 2014; 20(2):192-7. PubMed ID: 24387050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
